TrianglePUBLICATIONS · 38889737
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Haematol
- Publication date
- 2024 Aug
- First author
- Linton KM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Linton KM
- type
- Author
- name
- Vitolo U
- type
- Author
- name
- Jurczak W
- type
- Author
- name
- Lugtenburg PJ
- type
- Author
- name
- Gyan E
- type
- Author
- name
- Sureda A
- type
- Author
- name
- Christensen JH
- type
- Author
- name
- Hess B
- type
- Author
- name
- Tilly H
- type
- Author
- name
- Cordoba R
- type
- Author
- name
- Lewis DJ
- type
- Author
- name
- Okada C
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Linton KM
- type
- Author
- name
- Vitolo U
- type
- Author
- name
- Jurczak W
- type
- Author
- name
- Lugtenburg PJ
- type
- Author
- name
- Gyan E
- type
- Author
- name
- Sureda A
- type
- Author
- name
- Christensen JH
- type
- Author
- name
- Hess B
- type
- Author
- name
- Tilly H
- type
- Author
- name
- Cordoba R
- type
- Author
- name
- Lewis DJ
- type
- Author
- name
- Okada C
- type
- Author
- bibliography ids
- nci-bib-e994ca53697c1b3ec12b6023
- book metadata
- content sha256
- 820d89d11f1a6e3d8bc062283cced81be03b88b4ed64a26b911e4f71b1a775f2
- document type
- citation
- dois
- 10.1016/S2352-3026(24)00166-2
- electronic publication date
- display
- 2024 Jun 15
- precision
- day
- year
- 2024
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:38889737
- immutable id
- pubmed:38889737@820d89d11f1a6e3d8bc062283cced81be03b88b4ed64a26b911e4f71b1a775f2
- journal
- abbreviation
- Lancet Haematol
- issn electronic
- 2352-3026
- issn print
- Source null
- issue
- 8
- name
- The Lancet. Haematology
- nlm unique id
- 101643584
- pages
- e593-e605
- volume
- 11
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 38889737
- provenance
- batch id
- 3e43afde6f26fc8df6da
- provider
- NCBI PubMed ESummary
- record sha256
- 7da77defcafaa19067b18b217bfea93617aefc2761e9b6ab7cac8b0cee47fccd
- response sha256
- fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
- retrieved at
- 2026-09-09T23:48:21.145285+00:00
- publication date
- display
- 2024 Aug
- precision
- month
- year
- 2024
- publication types
- Journal Article
- Clinical Trial, Phase II
- Multicenter Study
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study.
Preserved source evidence · Independent clinical review pending · Not medical advice